PROM1 and colonic neoplasm: The cell line HT-29 has a CD133+ population of 47.5–95% in the literature [18], [19] and isolated CD133+ cells from the HT-29 colon cancer cell line exhibited a higher tumorigenic potential than CD133− cells in the in vivo tumor formation assay [20].